SMS Pharmaceuticals has informed that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec, 173 of the Companies Act, 2013, a meeting of the Board of Directors of the Company, to consider and approve the Un-audited Financial results of the Company for the third Quarter and nine months ended 31st December, 2019. The company has informed that Insider Trading window of the Company shall remain closed till 14th February, 2020 in view of the above mentioned Board Meeting.
The above information is a part of company’s filings submitted to BSE.
